Aumenta le possibilità di ricevere una risposta da questo datore di lavoro
Il tuo curriculum e una lettera di presentazione personalizzati, che corrispondono esattamente a ciò che sta cercando.
Circulants is seeking an experienced Product Owner/Lead for its Cell Therapy Strategic Initiatives. You will translate strategic priorities into a prioritized roadmap and drive cross-functional teams across clinical, manufacturing, and IT to deliver measurable outcomes in the vein-to-vein journey.
The role emphasizes AI-native workflows, GxP compliance, and collaboration with partners to align schedules, onboarding, and data analytics for commercial scale-up.
Circulants is seeking an experienced Product Owner/Lead to join a Tier 1 biopharmaceutical client's Cell Therapy organization and help lead strategic initiatives across its autologous and allogeneic portfolio. You will sit at the intersection of science, manufacturing, patient operations and digital, translating strategic priorities into a clear, prioritized product roadmap and driving cross-functional teams to deliver measurable outcomes. The initiatives in scope span the cell therapy value chain, including vein-to-vein patient journey orchestration, chain of identity / chain of custody (COI/COC), manufacturing scheduling and slot management, treatment-center onboarding, and data and analytics capabilities that support commercial scale-up. This role is AI-native by design. We are looking for a Product Owner who treats AI as a daily working partner: someone fluent in using AI assistants and copilots to take product deliverables from idea to done faster and at higher quality, and who knows how to apply them responsibly in a regulated GxP environment
Own the product vision, roadmap and backlog for one or more cell therapy strategic initiatives, aligned to portfolio and business objectives.
Partner with stakeholders across Clinical Operations, CMC/Manufacturing, Quality, Supply Chain, Patient Services, Commercial, Medical Affairs and IT to gather, refine and prioritize requirements.
Write clear epics, user stories and acceptance criteria; lead backlog refinement, sprint planning, reviews and retrospectives with delivery teams. Page 1 of 4 Product Owner/Lead – Cell Therapy Strategic Initiatives Work AI-first: use generative AI tools (e.g., ChatGPT, Claude, Microsoft Copilot) to draft and refine product deliverables such as PRDs, epics, user stories, acceptance criteria, process maps, release notes and executive updates, and to synthesize stakeholder input and data, applying human review to every output for accuracy, confidentiality and compliance.
Champion responsible AI adoption within the product team by sharing prompts, templates and AI-assisted workflows that raise delivery speed and quality.
Map and improve end-to-end vein-to-vein processes, identifying bottlenecks in apheresis scheduling, logistics, manufacturing and infusion.
Ensure solutions meet GxP, 21 CFR Part 11, data integrity (ALCOA+) and computer system validation (CSV/CSA) expectations, working closely with Quality and Validation.
Define success metrics and KPIs (e.g., turnaround time, slot utilization, out-of-spec rates, site activation time) and report progress to senior leadership.
Manage vendor and technology partners (e.g., cell therapy orchestration platforms, MES, LIMS, ERP) through evaluation, implementation and continuous improvement.
Identify risks and dependencies, drive decisions and keep initiatives on schedule and within budget.
Act as a change leader, preparing stakeholders and sites for new processes and systems.
Bachelor's degree in Life Sciences, Engineering, Information Systems, Business or a related field.
7+ years of experience in biopharma, biotech or life-sciences technology, including 4+ years as a Product Owner, Product Manager or equivalent role.
Hands-on experience in cell and gene therapy (CGT), with a working understanding of the autologous and/or allogeneic patient journey and manufacturing workflow.
Proven track record leading cross-functional initiatives in a matrixed, global organization.
Strong command of Agile/Scrum practices and backlog tools (e.g., Jira, Azure DevOps, Confluence). Working knowledge of GxP, 21 CFR Part 11, data integrity and validation requirements for regulated systems
Excellent written and verbal communication, with the ability to present to senior leaders and translate between scientific, operational and technical audiences.
Ability to work on-site in the Los Angeles area as required.
Authorization to work in the United States.
AI-native working style: demonstrated, day-to-day use of generative AI tools to plan, write, analyze and deliver product work (requirements, roadmaps, backlog refinement, research synthesis, presentations), with the judgment to verify outputs and protect confidential and patient data.
Advanced degree (MS, PhD, PharmD or MBA).
Experience with commercial-stage CAR-T, TCR-T or other cell therapy products, including launch or scale-up.
Direct experience with cell therapy orchestration and COI/COC platforms (e.g., TrakCel, Vineti/Title21, Salesforce Health Cloud) or MES/LIMS/ERP systems such as SAP, Veeva Vault, or Werum PAS-X. Background in apheresis center or treatment-center network onboarding and activation.
Certified Scrum Product Owner (CSPO), SAFe POPM, or PMP certification.
Experience defining data and analytics products, including dashboards and KPI frameworks for supply chain or manufacturing operations.
Exposure to AI/ML or advanced analytics use cases in manufacturing, forecasting or patient operations. Prior consulting or client-facing experience at a Tier 1 pharmaceutical company.
Familiarity with FDA, EMA and global regulatory expectations for advanced therapy medicinal products (ATMPs).
Experience building AI-assisted workflows, custom GPTs or agents, or prompt libraries for product teams, or contributing to AI governance and validation in a GxP regulated environment.
First 90 days: Build relationships with key stakeholders, assess the current-state vein-to-vein process, and deliver a prioritized roadmap with agreed KPIs. Page 3 of 4 Product Owner/Lead – Cell Therapy Strategic Initiatives.
6 months: Ship the first set of roadmap releases on time, with measurable gains on at least one priority KPI. 12 months: Recognized by the client as the go-to owner for the initiative, with sustained adoption across sites and a clear backlog for the next phase.
Circulants partners with leading life-sciences and medtech organizations to deliver specialized talent and expertise on high-impact programs. In this role you will work on therapies that change patients' lives, with the support of a team that invests in your growth and long-term career. Circulants is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, veteran status or any other protected characteristic. Qualified applicants with arrest or conviction records will be considered in accordance with the Los Angeles Fair Chance Initiative for Hiring and the California Fair Chance Act.